• 1
    Coolican SA, Samuel DS, Ewton DZ et al . The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 1997; 272: 665362.
  • 2
    Butt AJ, Dickson KA, McDougall F et al . Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 2003; 278: 29 67685.
  • 3
    Mohan S, Nakao Y, Honda Y et al . Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 1995; 270: 20 42431.
  • 4
    Jones JI, Gockerman A, Busby WH Jr. et al . Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 1993; 121: 67987.
  • 5
    Andress DL, Loop SM, Zapf J et al . Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun 1993; 195: 2530.
  • 6
    Hsieh T, Gordon RE, Clemmons DR et al . Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins. J Biol Chem 2003; 278: 42 88692.
  • 7
    Salih DA, Tripathi G, Holding C et al . Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci 2004; 101: 431419.
  • 8
    Perks CM, McCaig C, Clarke JB et al . Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells. Biochem Biophys Res Commun 2002; 294: 9951000.
  • 9
    Berfield AK, Andress DL, Abrass CK. IGFBP-5 (201–218) stimulates Cdc42GAP aggregation and filopodia formationin migrating mesangial cells. Kidney Int 2000; 57: 19912003.
  • 10
    Abrass CK, Berfield AK, Andress DL. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration. Am J Physiol 1997; 273: F899906.
  • 11
    Xu Q, Yan B, Li S et al . Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes its ligand-dependent action on cell migration. J Biol Chem 2004; 279: 426977.
  • 12
    McCaig C, Perks CM, Holly JM. Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci 2002; 115: 4293303.
  • 13
    Hao X, Sun B, Hu L et al . Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 2004; 100: 111022.
  • 14
    Wang H, Wang H, Zhang W et al . Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat 2006; 5: 1959.
  • 15
    Wang H, Rosen DG, Wang H et al . Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol 2006; 19: 114956.
  • 16
    Van‘t Veer LJ, Dai H, Van De Vijver MJ et al . Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 5306.
  • 17
    Hu Z, Bonifas JM, Aragon G et al . Evidence for lack of enhanced hedgehog target gene expression in common extracutaneous tumors. Cancer Res 2003; 63: 9238.
  • 18
    Butt AJ, Dickson KA, Jambazov S et al . Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells. Endocrinology 2005; 146: 311322.
  • 19
    McCaig C, Perks CM, Holly JM. Signalling pathways involved in the direct effects of IGFBP-5 on breast epithelial cell attachment and survival. J Cell Biochem 2002; 84: 78494.
  • 20
    Yee D, Sharma J, Hilsenbeck SG. Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer. J Natl Cancer Inst 1994; 86: 17859.
  • 21
    Hewitt SC, Deroo BJ, Hansen K et al . Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol Endocrinol 2003; 17: 207083.